MedTrace Logo

Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol

NCT00639145 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2021-02-08

No results posted yet for this study

Summary

The purpose of this study is to find out if antiretroviral drugs are safe and well tolerated by HIV-positive pregnant women and their infants in South Africa and Zambia.

Conditions

  • HIV Infections
  • HIV Positive
  • Pregnant Women

Sponsors & Collaborators

  • Harvard School of Public Health (HSPH)

    collaborator OTHER

  • Centre for Infectious Disease Research in Zambia (CIDRZ)

    collaborator UNKNOWN

  • University of Limpopo MEDUNSA

    collaborator UNKNOWN

  • Health Systems Trust

    collaborator OTHER

  • Elizabeth Glaser Pediatric AIDS Foundation

    lead OTHER

Principal Investigators

  • Richard Marlink, MD · Elizabeth Glaser Pediatric AIDS Foundation

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • South Africa
  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00639145 on ClinicalTrials.gov